The role of unfolded protein response-associated miRNAs in immunogenic cell death amplification: A literature review and bioinformatics analysis
- PMID: 36586572
- DOI: 10.1016/j.lfs.2022.121341
The role of unfolded protein response-associated miRNAs in immunogenic cell death amplification: A literature review and bioinformatics analysis
Abstract
Immunogenic cell death (ICD) is a type of cellular death that is elicited in response to the specific types of anti-cancer therapies and enhances the anti-tumor immune responses by the combination of antigenicity and adjuvanticity of dying tumor cells. There is a well-established interlink between endoplasmic reticulum stress (ERS) and ICD elicited by anti-cancer therapies. Most recent evidences support that unfolded protein response (UPR)-associated miRNAs can be key players in the ERS-induced ICD. Hence, in the present study, we conducted a literature review on the role of these miRNAs and associated molecular pathways that may regulate ICD. We first collected UPR-associated miRNAs that promote ERS-induced apoptosis and then focused on microRNAs (miRNAs) that promote ERS-induced apoptosis via PERK/eIF2α/ATF4/CHOP pathway activation, as the main core for ICD and release of damage-associated molecular patterns. To better identify PERK/eIF2α/ATF4/CHOP pathway-inducing miRNAs that can be used as potential therapeutic targets for improving ICD in cancer treatment, we did a comprehensive bioinformatics analysis and network construction. Our results showed that "pathways in cancer", "MAPK signaling pathway", "PI3K-Akt signaling pathway", and "Cellular senescence", which correlate with UPR components and ERS induction, were among the significant signaling pathways related to the target genes of these miRNAs. Furthermore, a protein-protein interaction (PPI) network was constructed, which revealed the involvement of the PPI-extracted hub genes in the regulation of proliferation and apoptosis. In conclusion, we propose that these types of miRNAs can be considered as the potential cancer therapy options for better induction of ICD in combination with other ICD inducers.
Keywords: Bioinformatics; Cancer therapy; Endoplasmic reticulum stress; Immunogenic cell death; Unfolded protein response; miRNAs.
Copyright © 2022 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors have no competing of interests to declaim.
Similar articles
-
The Role of the PERK/eIF2α/ATF4/CHOP Signaling Pathway in Tumor Progression During Endoplasmic Reticulum Stress.Curr Mol Med. 2016;16(6):533-44. doi: 10.2174/1566524016666160523143937. Curr Mol Med. 2016. PMID: 27211800 Free PMC article. Review.
-
PERK-eIF2α-ATF4 pathway mediated by endoplasmic reticulum stress response is involved in osteodifferentiation of human periodontal ligament cells under cyclic mechanical force.Cell Signal. 2016 Aug;28(8):880-6. doi: 10.1016/j.cellsig.2016.04.003. Epub 2016 Apr 11. Cell Signal. 2016. PMID: 27079961
-
The PERK/PKR-eIF2α Pathway Negatively Regulates Porcine Hemagglutinating Encephalomyelitis Virus Replication by Attenuating Global Protein Translation and Facilitating Stress Granule Formation.J Virol. 2022 Jan 12;96(1):e0169521. doi: 10.1128/JVI.01695-21. Epub 2021 Oct 13. J Virol. 2022. PMID: 34643429 Free PMC article.
-
Mechanism of the induction of endoplasmic reticulum stress by the anti-cancer agent, di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT): Activation of PERK/eIF2α, IRE1α, ATF6 and calmodulin kinase.Biochem Pharmacol. 2016 Jun 1;109:27-47. doi: 10.1016/j.bcp.2016.04.001. Epub 2016 Apr 6. Biochem Pharmacol. 2016. PMID: 27059255
-
Fanning the Flames of Endoplasmic Reticulum (ER) Stress: Can Sphingolipid Metabolism Be Targeted to Enhance ER Stress-Associated Immunogenic Cell Death in Cancer?Mol Pharmacol. 2024 Feb 15;105(3):155-165. doi: 10.1124/molpharm.123.000786. Mol Pharmacol. 2024. PMID: 38164594 Free PMC article. Review.
Cited by
-
Targeting endoplasmic reticulum stress-induced lymphatic dysfunction for mitigating bisphosphonate-related osteonecrosis.Clin Transl Med. 2024 Nov;14(11):e70082. doi: 10.1002/ctm2.70082. Clin Transl Med. 2024. PMID: 39521624 Free PMC article.
-
Investigating the potential role of miR-451a as a tumor suppressor in immunogenic cell death induction and dendritic cell maturation in colorectal cancer cell lines.Cancer Cell Int. 2025 Aug 7;25(1):297. doi: 10.1186/s12935-025-03919-3. Cancer Cell Int. 2025. PMID: 40770807 Free PMC article.
-
Clinical application of immunogenic cell death inducers in cancer immunotherapy: turning cold tumors hot.Front Cell Dev Biol. 2024 May 7;12:1363121. doi: 10.3389/fcell.2024.1363121. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 38774648 Free PMC article. Review.
-
A new paradigm for cancer immunotherapy: targeting immunogenic cell death-related noncoding RNA.Front Immunol. 2025 Jan 23;15:1498781. doi: 10.3389/fimmu.2024.1498781. eCollection 2024. Front Immunol. 2025. PMID: 39916954 Free PMC article. Review.
-
Tumor cell membrane-based vaccines: A potential boost for cancer immunotherapy.Exploration (Beijing). 2024 Mar 28;4(6):20230171. doi: 10.1002/EXP.20230171. eCollection 2024 Dec. Exploration (Beijing). 2024. PMID: 39713208 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials